Truist downgraded Integral Ad Science (IAS) to Hold from Buy with a price target of $10.30, down from $17, after the company agreed to be acquired by private equity firm Novacap for $10.30 per share in cash.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on IAS:
- Positive Outlook for IAS Following Novacap Acquisition: Buy Rating Affirmed by Analyst Andrew Marok
- Integral Ad Science acquisition by Novacap ‘makes sense,’ says Raymond James
- Integral Ad Science PE takeout a positive, says Barclays
- Integral Ad Science downgraded to Hold from Buy at Craig-Hallum
- Integral Ad Science to be acquired by Novacap for $1.9B in cash